Heterocyclic antiviral compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 498/10 (2006.01) A61K 31/537 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2682639

This invention relates to piperidine derivatives of formula (I) wherein R1, R2, R3 and R4 are as defined herein useful in the treatment of a variety of disorders, including those in which the modulation of CCR5 receptors is implicated. Disorders that may be treated or prevented by the present derivatives include HIV and genetically related retroviral infections (and the resulting acquired immune deficiency syndrome, AIDS), rheumatoid arthritis, solid organ transplant reject (graft vs. host disease), asthma and COPD.

Cette invention porte sur des dérivés de pipéridine de formule (I) dans laquelle R1, R2, R3 et R4 sont tels que définis présentement, utiles dans le traitement d'une diversité de troubles, comprenant ceux dans lesquels la modulation de récepteurs de CCR5 est impliquée. Les troubles qui peuvent être traités ou prévenus par les présents dérivés comprennent les infections par le VIH et les rétrovirus génétiquement apparentés (et le syndrome d'immunodéficience acquise résultant, SIDA), l'arthrite rhumatoïde, le rejet de greffe d'organe solide (réaction du greffon contre l'hôte), l'asthme et la bronchopneumopathie chronique obstructive (COPD).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic antiviral compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic antiviral compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic antiviral compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1438446

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.